CN112007060A - 一种祛疣祛斑组合物及制备方法 - Google Patents
一种祛疣祛斑组合物及制备方法 Download PDFInfo
- Publication number
- CN112007060A CN112007060A CN202010968593.6A CN202010968593A CN112007060A CN 112007060 A CN112007060 A CN 112007060A CN 202010968593 A CN202010968593 A CN 202010968593A CN 112007060 A CN112007060 A CN 112007060A
- Authority
- CN
- China
- Prior art keywords
- parts
- composition
- warts
- freckles
- wart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000010153 skin papilloma Diseases 0.000 title claims abstract description 108
- 208000000260 Warts Diseases 0.000 title claims abstract description 107
- 239000000203 mixture Substances 0.000 title claims abstract description 104
- 208000003351 Melanosis Diseases 0.000 title claims abstract description 64
- 238000002360 preparation method Methods 0.000 title abstract description 9
- 241001116389 Aloe Species 0.000 claims abstract description 43
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 43
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 31
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 27
- 206010014970 Ephelides Diseases 0.000 claims abstract description 23
- 239000002253 acid Substances 0.000 claims abstract description 22
- 235000010889 Rhus javanica Nutrition 0.000 claims abstract description 20
- 239000000706 filtrate Substances 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 239000007788 liquid Substances 0.000 claims description 47
- 239000003814 drug Substances 0.000 claims description 45
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims description 40
- 238000002156 mixing Methods 0.000 claims description 33
- 229960000271 arbutin Drugs 0.000 claims description 20
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims description 20
- 244000097577 Rhus javanica Species 0.000 claims description 19
- 241000173529 Aconitum napellus Species 0.000 claims description 16
- 229940023019 aconite Drugs 0.000 claims description 16
- 239000013067 intermediate product Substances 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 13
- 241000132012 Atractylodes Species 0.000 claims description 11
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims description 11
- 239000000839 emulsion Substances 0.000 claims description 11
- 239000003381 stabilizer Substances 0.000 claims description 11
- 239000002562 thickening agent Substances 0.000 claims description 11
- 241001289529 Fallopia multiflora Species 0.000 claims description 10
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 9
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 9
- 241000208422 Rhododendron Species 0.000 claims description 9
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 9
- 241000045403 Astragalus propinquus Species 0.000 claims description 8
- 240000002943 Elettaria cardamomum Species 0.000 claims description 8
- 235000006533 astragalus Nutrition 0.000 claims description 8
- 235000005300 cardamomo Nutrition 0.000 claims description 8
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 8
- 238000000227 grinding Methods 0.000 claims description 8
- 235000011477 liquorice Nutrition 0.000 claims description 8
- 235000013372 meat Nutrition 0.000 claims description 8
- 241000213006 Angelica dahurica Species 0.000 claims description 6
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 5
- 235000002906 tartaric acid Nutrition 0.000 claims description 5
- 239000011975 tartaric acid Substances 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 4
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 241000304195 Salvia miltiorrhiza Species 0.000 claims 2
- 240000001949 Taraxacum officinale Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 206010028980 Neoplasm Diseases 0.000 abstract description 13
- 231100000241 scar Toxicity 0.000 abstract description 7
- 208000032544 Cicatrix Diseases 0.000 abstract description 6
- 230000037387 scars Effects 0.000 abstract description 6
- 230000009286 beneficial effect Effects 0.000 abstract description 5
- 235000005911 diet Nutrition 0.000 abstract description 3
- 230000000378 dietary effect Effects 0.000 abstract description 3
- 210000004243 sweat Anatomy 0.000 abstract description 2
- 241001533159 Brucea javanica Species 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 238000005303 weighing Methods 0.000 description 25
- 230000001737 promoting effect Effects 0.000 description 14
- 241000701806 Human papillomavirus Species 0.000 description 11
- 239000009969 fructus bruceae Substances 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- UKWHYYKOEPRTIC-UHFFFAOYSA-N mercury(ii) oxide Chemical compound [Hg]=O UKWHYYKOEPRTIC-UHFFFAOYSA-N 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 241000245665 Taraxacum Species 0.000 description 9
- 230000036407 pain Effects 0.000 description 9
- 244000132619 red sage Species 0.000 description 9
- 206010052428 Wound Diseases 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 239000000049 pigment Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 229940101209 mercuric oxide Drugs 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000002791 soaking Methods 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000000857 drug effect Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 241000934136 Verruca Species 0.000 description 3
- 229940107666 astragalus root Drugs 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 208000035269 cancer or benign tumor Diseases 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 229920000832 Cutin Polymers 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000009608 Papillomavirus Infections Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 201000003265 lymphadenitis Diseases 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 1
- 241000227129 Aconitum Species 0.000 description 1
- 208000000197 Acute Cholecystitis Diseases 0.000 description 1
- 208000008710 Amebic Dysentery Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010001986 Amoebic dysentery Diseases 0.000 description 1
- 244000059800 Amomum compactum Species 0.000 description 1
- 235000016426 Amomum compactum Nutrition 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010059313 Anogenital warts Diseases 0.000 description 1
- 235000012871 Arctostaphylos uva ursi Nutrition 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000158621 Brucea Species 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 206010008614 Cholecystitis acute Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 241000132536 Cirsium Species 0.000 description 1
- 241001517488 Clavus Species 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010068322 Oral papilloma Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 241000242678 Schistosoma Species 0.000 description 1
- 241001093962 Simaroubaceae Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241001330502 Stephania Species 0.000 description 1
- 206010042658 Sweat gland tumour Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 244000003892 Vaccinium erythrocarpum Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229940039750 aconitine Drugs 0.000 description 1
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 201000004196 common wart Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000024121 nodulation Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 201000004303 plantar wart Diseases 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000004022 syringoma Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提出了一种祛疣祛斑组合物及制备方法,涉及皮肤疣技术领域。该祛疣祛斑组合物,包括去除剂,所述去除剂主要由如下重量份的原料制备而成:鸦胆子油40~60份和果酸30~40份。本发明的优点在于,通过分类多次煎煮合并滤液,同时低温提取新鲜芦荟汁,最终制备的祛疣祛斑组合物中含有大量的有益成分,达到快速无痛去除疣、汗管瘤等赘生物和斑块的效果,随治随走,无需忌口,后期不留疤。
Description
技术领域
本发明涉及赘生物技术领域,具体而言,涉及一种祛疣祛斑组合物及制备方法。
背景技术
赘生物是机体或器官内外面在病理过程中形成的各种突出物的总称。如皮肤疣就是一类经常困扰人们的赘生物。疣是人体皮肤或粘膜感染人类***瘤病毒(HPV)后引起的表皮新生物,虽无大碍,但可影响容貌、学***疣、跖疣、***、口腔疣、咽喉疣等。
目前,对于皮肤疣主要有以下几类治疗方式:
1、物理及手术方法,这类方法可快速准确地去除可见疣体,但操作复杂,需要借助仪器或其他工具进行去除,去除过程中需要局部麻醉;由于需要彻底清除皮肤疣,因此会将皮肤疣附近的健康组织也去除一些,保证局部无HPV感染的细胞;此外,术后易被细菌感染,并且麻醉失效后疼痛难忍,给患者造成一定的生活困扰,并且在后期,创口还会留疤,对患者的外表造成影响;
2、外用化学药物:这类方法的优点是使用或治疗方式简便,创面较小,不会影响客户的日常生活,但这类药物需要使用较长的时间才有可能治疗痊愈,整体治愈率差,并且由于水平不一,很多药物还可能引起水肿、糜烂甚至坏死等。
因此,需要研发一种可快速治疗皮肤疣等赘生物、创口小且不留疤的治疗药物。
发明内容
本发明的目的在于提供一种祛疣祛斑组合物,此祛疣祛斑组合物可快速无痛去除疣、汗管瘤等赘生物和斑块,随治随走,无需忌口,后期不留疤。
本发明的另一目的在于提供一种前述祛疣祛斑组合物的制备方法,该制备方法通过分类分次煎煮,并低温提取新鲜芦荟汁,充分提取各原料中的有益成分,提升药效。
本发明解决其技术问题是采用以下技术方案来实现的。
一方面,本申请实施例提供一种祛疣祛斑组合物,包括去除剂,所述去除剂主要由如下重量份的原料制备而成:鸦胆子油40~60份和果酸30~40份。
本发明提供的祛疣祛斑组合物所用原料如下:
鸦胆子:是苦木科鸦胆子属植物,以果实和叶入药,为较常用中药。味苦,性寒,有小毒。具有清热燥湿、杀虫、止痢的功能。主治阿米巴痢疾、早期血吸虫、菌痢,外用治鸡眼、皮疣等。
果酸:就是从水果中提取的各种有机酸,是存在于多种天然水果或酸奶中的有效成分。包含葡萄酸、苹果酸、柑橘酸及乳酸等,因大多数由水果中提炼,故称果酸。其中以自甘蔗中提炼的甘醇酸运用最广。
熊果苷:又名熊果素,呈白色针状结晶或粉末。萃取自熊果的叶子,能够通过抑制体内酪氨酸酶的活性,阻止黑色素的生成,从而减少皮肤色素沉积,祛除色斑和雀斑,同时还有杀菌、消炎的作用。
杜鹃花:杜鹃花具有镇咳、祛痰、平喘、抗菌、抗炎及调整心血管***的作用,可用于治疗脓肿、溃疡、肿瘤、皮肤病、痔疮、发疹、风湿、支气管炎等症。
何首乌:又名多花蓼、紫乌藤、夜交藤等。苦、甘、涩,温。归肝、心、肾经。解毒,消痈,润肠通便。用于瘰疠疮痈,风疹瘙痒,肠燥便秘;高血脂。
白豆蔻:为姜科植物。味辛、性温,归肺、脾、胃经,功效化湿,行气,温中,止呕。
白芷:以根入药,有祛病除湿、排脓生肌、活血止痛等功能。主治风寒感冒、头痛、鼻炎、牙痛。赤白带下、痛疖肿毒等症,亦可作香料。
白术:别名桴蓟,于术,冬白术,淅术,杨桴,吴术,片术、苍术等。白术具有健脾益气,燥湿利水,止汗,安胎的功效,用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。现代医学证明,白术及其提取物具有利尿、降血糖、健脾胃、壮身体、提高抗病能力、抗凝血、抗肿瘤、调整胃肠平滑肌以及抗菌作用。
甘草:调和诸药药效。
升药:排毒去脓,去腐生肌。主治痈疽疮毒,溃后浓少,腐肉不脱,新肉难生。
蒲公英:菊科,蒲公英属多年生草本植物;清热解毒,利尿散结。治急性乳腺炎,淋巴腺炎,瘰疬,疔毒疮肿,急性结膜炎,感冒发热,急性扁桃体炎,急性支气管炎,胃炎,肝炎,胆囊炎,***。
黄芪:又名绵芪,现代医学证明黄芪及其提取物具有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。
丹参:种根入药,含丹参酮,为强壮性通经剂,有祛瘀、生新、活血、调经等效用,为妇科要药,主治子宫出血,***,血瘀,腹痛,经痛,经闭,庙痛。对治疗冠心病有良好效果。此外亦治神经性衰弱失眠,关节痛,贫血,乳腺炎,淋巴腺炎,关节炎,疮疖痛肿,丹毒,急慢性肝炎,肾孟肾炎,跌打损伤,晚期血吸虫病肝脾肿大,癫癎。外用又可洗漆疮。
乌头:为毛茛科植物,母根叫乌头,为镇静剂,冶风庳,风湿神经痛。侧根(子根)入药,叫附子。有回阳、逐冷、祛风湿的作用。治大汗亡阳、四肢厥逆、霍乱转筋、肾阳衰弱的腰膝冷痛、形寒爱冷、精神不振以及风寒湿痛、脚气等症。
另一方面,本申请实施例提供一种前述祛疣祛斑组合物的制备方法,包括如下步骤:(1)将乌头煎煮三次,合并滤液后浓缩,得到药液一;(2)将白芷、升药、丹参、杜鹃花、何首乌、白豆蔻、白术、甘草、蒲公英和黄芪混合后煎煮三次,合并滤液后浓缩,得到药液二;(3)将芦荟低温磨碎,去肉收集汁液,得到芦荟汁;(4)将药液一、药液二、芦荟汁和pH调节剂于搅拌装置中混匀,再加入鸦胆子油、果酸和熊果苷,搅拌均匀后得到中间产物,向中间产物中加入增稠剂和乳化稳定剂,混合均匀后,即得到所述祛疣祛斑组合物。
综上,相对于现有技术,本发明的实施例至少具有如下优点或有益效果:
本发明提供的祛疣祛斑组合物,利用果酸将皮肤疣表面的老化角质一次剥落,同时果酸的高渗透力能促进渗透到肌肤内里,辅助鸦胆子油作用于皮肤疣,由于鸦胆子油本身对肌肤具有强烈的刺激性,添加适量果酸后,在能达到相同去除率的基础上减少鸦胆子油的用量,可在去除皮肤疣过程中减少患者的痛楚。整体而言,本发明提供的祛疣祛斑组合物可有效治疗斑、皮肤疣等赘生物,同时由于该祛疣祛斑组合物可靶向提取色素,深层渗透分解底层色素,后期不会留疤,且无反复,随治随走,无需忌口,可长期抵抗HPV病毒的作用。
此外,本发明的另一目的在于提供一种前述祛疣祛斑组合物的制备方法,该制备方法通过分类分次煎煮,并低温提取新鲜芦荟汁,充分提取各原料中的有益成分,提升药效。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面将对本发明实施例中的技术方案进行清楚、完整地描述。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。
本申请实施例提供一种祛疣祛斑组合物,包括去除剂,所述去除剂主要由如下重量份的原料制备而成:鸦胆子油40~60份和果酸30~40份。
在本发明的一些实施例中,上述祛疣祛斑组合物中的去除剂主要由如下重量份的原料制备而成:鸦胆子油50份和果酸30份。
在本发明的一些实施例中,上述祛疣祛斑组合物中还包括乌头20~30重量份。
在本发明的一些实施例中,上述祛疣祛斑组合物中还包括修复组合物,所述修复组合物主要由如下重量份的原料制备而成:白芷20~40份、升药60~80份和丹参40~60份。
在本发明的一些实施例中,上述祛疣祛斑组合物中的修复组合物主要由如下重量份的原料制备而成:白芷30份、升药60份和丹参40份。
在本发明的一些实施例中,上述祛疣祛斑组合物中的修复组合物还包括熊果苷40~60重量份。
在本发明的一些实施例中,上述祛疣祛斑组合物中的修复组合物还包括熊果苷50重量份。
在本发明的一些实施例中,上述祛疣祛斑组合物中的修复组合物还包括如下重量份的原料,杜鹃花40~80份、何首乌20~40份、白豆蔻30~50份、白术40~60份、甘草20~30份、蒲公英10~20份和黄芪20~40份。
在本发明的一些实施例中,上述祛疣祛斑组合物中的修复组合物还包括芦荟130~150重量份。
另一方面,本申请实施例提供一种前述祛疣祛斑组合物的制备方法,包括如下步骤:(1)将乌头煎煮三次,合并滤液后浓缩,得到药液一;(2)将白芷、升药、丹参、杜鹃花、何首乌、白豆蔻、白术、甘草、蒲公英和黄芪混合后煎煮三次,合并滤液后浓缩,得到药液二;(3)将芦荟低温磨碎,去肉收集汁液,得到芦荟汁;(4)将药液一、药液二、芦荟汁和pH调节剂于搅拌装置中混匀,再加入鸦胆子油、果酸和熊果苷,搅拌均匀后得到中间产物,向中间产物中加入增稠剂和乳化稳定剂,混合均匀后,即得到所述祛疣祛斑组合物。
以下结合实施例对本发明的特征和性能作进一步的详细描述。
实施例1
本实施例的目的在于提供一种祛疣祛斑组合物,具体包括如下步骤:
(1)准确称量鸦胆子油40g、果酸35g,备用;
(2)称取乌头20g,按料液比1:20称量清水,将清水分三次加入乌头中煎煮,合并三次煎煮滤液并浓缩至5mL,得到药液一;
(3)称取白芷20g、升药60g、丹参45g、杜鹃花40g、何首乌30g、白豆蔻35g、白术40g、甘草30g、蒲公英10g和黄芪25g,混合后得到混合物,将混合物浸泡1h,按混合物和水的料液比1:20称量清水,将清水分三次加入混合物中煎煮,合并三次滤液并浓缩至15mL,得到药液二;
(4)取新鲜芦荟叶,洗净去刺并去除老叶等杂质,得到140g芦荟叶,低温磨碎,去肉后收集汁液,得到芦荟汁;
(5)将药液一、药液二、芦荟汁和pH调节剂于搅拌装置中混匀,再加入鸦胆子油、果酸和熊果苷,熊果苷用量为40g;搅拌均匀后得到中间产物,向中间产物中加入增稠剂和乳化稳定剂,混合均匀后,即得到所述祛疣祛斑组合物。
实施例2
本实施例的目的在于提供一种祛疣祛斑组合物,具体包括如下步骤:
(1)准确称量鸦胆子油45g、果酸38g,备用;
(2)称取乌头23g,按料液比1:20称量清水,将清水分三次加入乌头中煎煮,合并三次煎煮滤液并浓缩至5mL,得到药液一;
(3)称取白芷25g、升药70g、丹参50g、杜鹃花50g、何首乌35g、白豆蔻30g、白术50g、甘草30g、蒲公英15g和黄芪20g,混合后得到混合物,将混合物浸泡1h,按混合物和水的料液比1:20称量清水,将清水分三次加入混合物中煎煮,合并三次滤液并浓缩至15mL,得到药液二;
(4)取新鲜芦荟叶,洗净去刺并去除老叶等杂质,得到145g芦荟叶,低温磨碎,去肉后收集汁液,得到芦荟汁;
(5)将药液一、药液二、芦荟汁和pH调节剂于搅拌装置中混匀,再加入鸦胆子油、果酸和熊果苷,熊果苷用量为45g;搅拌均匀后得到中间产物,向中间产物中加入增稠剂和乳化稳定剂,混合均匀后,即得到所述祛疣祛斑组合物。
实施例3
本实施例的目的在于提供一种祛疣祛斑组合物,具体包括如下步骤:
(1)准确称量鸦胆子油50g、果酸30g,备用;
(2)称取乌头25g,按料液比1:20称量清水,将清水分三次加入乌头中煎煮,合并三次煎煮滤液并浓缩至5mL,得到药液一;
(3)称取白芷30g、升药60g、丹参40g、杜鹃花80g、何首乌25g、白豆蔻40g、白术60g、甘草30g、蒲公英12g和黄芪30g,混合后得到混合物,将混合物浸泡1h,按混合物和水的料液比1:20称量清水,将清水分三次加入混合物中煎煮,合并三次滤液并浓缩至15mL,得到药液二;
(4)取新鲜芦荟叶,洗净去刺并去除老叶等杂质,得到150g芦荟叶,低温磨碎,去肉后收集汁液,得到芦荟汁;
(5)将药液一、药液二、芦荟汁和pH调节剂于搅拌装置中混匀,再加入鸦胆子油、果酸和熊果苷,熊果苷用量为60g;搅拌均匀后得到中间产物,向中间产物中加入增稠剂和乳化稳定剂,混合均匀后,即得到所述祛疣祛斑组合物。
实施例4
本实施例的目的在于提供一种祛疣祛斑组合物,具体包括如下步骤:
(1)准确称量鸦胆子油55g、果酸40g,备用;
(2)称取乌头28g,按料液比1:20称量清水,将清水分三次加入乌头中煎煮,合并三次煎煮滤液并浓缩至5mL,得到药液一;
(3)称取白芷25g、升药75g、丹参60g、杜鹃花70g、何首乌20g、白豆蔻50g、白术55g、甘草20g、蒲公英18g和黄芪35g,混合后得到混合物,将混合物浸泡1h,按混合物和水的料液比1:20称量清水,将清水分三次加入混合物中煎煮,合并三次滤液并浓缩至15mL,得到药液二;
(4)取新鲜芦荟叶,洗净去刺并去除老叶等杂质,得到130g芦荟叶,低温磨碎,去肉后收集汁液,得到芦荟汁;
(5)将药液一、药液二、芦荟汁和pH调节剂于搅拌装置中混匀,再加入鸦胆子油、果酸和熊果苷,熊果苷用量为50g;搅拌均匀后得到中间产物,向中间产物中加入增稠剂和乳化稳定剂,混合均匀后,即得到所述祛疣祛斑组合物。
实施例5
本实施例的目的在于提供一种祛疣祛斑组合物,具体包括如下步骤:
(1)准确称量鸦胆子油60g、果酸32g,备用;
(2)称取乌头30g,按料液比1:20称量清水,将清水分三次加入乌头中煎煮,合并三次煎煮滤液并浓缩至5mL,得到药液一;
(3)称取白芷40g、升药80g、丹参55g、杜鹃花60g、何首乌40g、白豆蔻40g、白术45g、甘草20g、蒲公英20g和黄芪40g,混合后得到混合物,将混合物浸泡1h,按混合物和水的料液比1:20称量清水,将清水分三次加入混合物中煎煮,合并三次滤液并浓缩至15mL,得到药液二;
(4)取新鲜芦荟叶,洗净去刺并去除老叶等杂质,得到135g芦荟叶,低温磨碎,去肉后收集汁液,得到芦荟汁;
(5)将药液一、药液二、芦荟汁和pH调节剂于搅拌装置中混匀,再加入鸦胆子油、果酸和熊果苷,熊果苷用量为55g;搅拌均匀后得到中间产物,向中间产物中加入增稠剂和乳化稳定剂,混合均匀后,即得到所述祛疣祛斑组合物。
需要注意的是,本发明提供的祛疣祛斑组合物即可以按照实施例1~5中制备,也可以按照如下方式制备:准确量取鸦胆子油30~50份、果酸30~40份和乌头20~30份(乌头的提取物,制取方式如实施例1~5中所示),混合后的得到去除剂;将剩余的10份鸦胆子油和其余的药液一、药液二、芦荟汁、pH调节剂、增稠剂和乳化稳定剂混合(提取方式及混合方式具体参见实施例1~5),得到修复组合物,微量的10份鸦胆子油可在修复组合物中起到抑制HPV病毒的作用。在使用时,先用去除剂涂于皮肤疣,20min分钟左右后清水洗净,消毒后涂覆修复组合物;去除剂使用时间视疣的大小而定。如果皮肤疣过于老化或者面积过大,可使用2~4次,每两天使用一次去除剂,针对大多数的皮肤疣,使用一次即可,即点即平;如果需要使用多次去除剂,则参照前述使用方式,再涂覆修复组合物,修复组合物每天更换一次,需要在最后一次使用去除剂后,连续使用5~15天,具体视皮肤疣创面而定。
本发明提供的祛疣祛斑组合物对赘生物有很好的去除疗效,创面小,不留疤,尤其适用于皮肤疣,连续使用3~7天即可,治愈率达到99%以上,同时对斑块等也具有很好的去除效果,斑块淡化率能达到98%以上,停用后不会反复。
前述实施例中所用pH调节剂、增稠剂和乳化稳定剂均为现有产品,可是视使用需求添加,也可以不添加,直接将药液一、药液二和芦荟汁混合,加入熊果苷、鸦胆子油和果酸,混合后也可的二到该祛疣祛斑组合物。需要注意的是,前述料液比均为质量比。如果用于去除斑块,可使用实施例1中提供的祛疣祛斑组合物,对于颜色较浅且皮肤敏感的患者,可将该祛疣祛斑组合物用植物油稀释调和后使用。
综上所述,本发明提供的祛疣祛斑组合物具有如下优点:
(1)鸦胆子是去除皮肤疣的常用中药,由于鸦胆子对正常皮肤、粘膜的刺激性大,在实际祛疣过程中,绝大多数患者自觉疼痛异常,使用感受不佳,同时,市面上利用鸦胆子去除皮肤疣的药物多为高浓度的鸦胆子油或膏,祛疣过程痛苦,同时因为皮肤疣去除过程中会造成一定程度的皮肤和粘膜损伤,容易在前一次去除皮肤疣的位置长出新的皮肤疣,即扩散和复发。因此,本发明提供的祛疣祛斑组合物利用果酸将皮肤疣表面的老化角质一次剥落,同时果酸的高渗透力能促进鸦胆子油中有效成分充分渗透到肌肤内里,辅助鸦胆子油作用于皮肤疣,由于鸦胆子油本身对肌肤具有强烈的刺激性,添加适量果酸后,在能达到相同去除率的基础上减少鸦胆子油的用量,可在去除皮肤疣过程中减少患者的痛楚;
(2)通过添加乌头提取物,利用其中的乌头碱等有效成分充分缓解祛疣过程中患处的疼痛,真正达到无痛祛疣的效果;
(3)通过添加白芷、升药和丹参,以白芷排脓生肌,活血止痛,以丹参通经活血,促进新肉生长,通过添加升药去腐生肌,使该祛疣祛斑组合物不仅能快速无痛去除皮肤疣,还能快速促进新肉生长,缩短治愈时间;
(4)通过添加熊果苷深度提取色素,阻止黑色素的形成,去除斑块,并且能防止患处的色素沉积,从而达到不留疤的效果;
(5)通过添加杜鹃花、何首乌、白豆蔻、白术、甘草、蒲公英和黄芪,抑制微生物生长,消毒杀菌,防止创口感染细菌而发炎,同时,白术还能起到抗凝血的功能,防止去除皮肤疣的位置渗血过多对健康组织造成感染,引起复发或扩散;
(6)通过添加芦荟,进一步降低鸦胆子的刺激性,使整个祛疣祛斑组合物在保持快速去除皮肤疣、促进新肉生长,不留疤的基础上更加温和。
整体而言,本发明提供的祛疣祛斑组合物可有效治疗斑、皮肤疣等赘生物,同时由于该祛疣祛斑组合物可靶向提取色素,深层渗透分解底层色素,后期不会留疤,且无反复,随治随走,无需忌口,可长期抵抗HPV病毒的作用。
此外,本发明的另一目的在于提供一种前述祛疣祛斑组合物的制备方法,该制备方法通过分类分次煎煮,并低温提取新鲜芦荟汁,充分提取各原料中的有益成分,提升药效。
以上所描述的实施例是本发明一部分实施例,而不是全部的实施例。本发明的实施例的详细描述并非旨在限制要求保护的本发明的范围,而是仅仅表示本发明的选定实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
Claims (10)
1.一种祛疣祛斑组合物,其特征在于,包括去除剂,所述去除剂主要由如下重量份的原料制备而成:鸦胆子油40~60份和果酸30~40份。
2.根据权利要求1所述的祛疣祛斑组合物,其特征在于,所述去除剂主要由如下重量份的原料制备而成:鸦胆子油50份和果酸30份。
3.根据权利要求1所述的祛疣祛斑组合物,其特征在于,还包括乌头20~30重量份。
4.根据权利要求1-3任意一项所述的祛疣祛斑组合物,其特征在于,还包括修复组合物,所述修复组合物主要由如下重量份的原料制备而成:白芷20~40份、升药60~80份和丹参40~60份。
5.根据权利要求4所述的祛疣祛斑组合物,其特征在于,所述修复组合物主要由如下重量份的原料制备而成:白芷30份、升药60份和丹参40份。
6.根据权利要求4所述的祛疣祛斑组合物,其特征在于,所述修复组合物还包括熊果苷40~60重量份。
7.根据权利要求6所述的祛疣祛斑组合物,其特征在于,所述修复组合物还包括如下重量份的原料,杜鹃花40~80份、何首乌20~40份、白豆蔻30~50份、白术40~60份、甘草20~30份、蒲公英10~20份和黄芪20~40份。
8.根据权利要求6所述的祛疣祛斑组合物,其特征在于,所述修复组合物还包括芦荟130~150重量份。
9.根据权利要求8所述的祛疣祛斑组合物,其特征在于,还包括pH调节剂、乳化稳定剂和增稠剂。
10.一种权利要求9所述的祛疣祛斑组合物的制备方法,其特征在于,包括如下步骤:
(1)将乌头煎煮三次,合并滤液后浓缩,得到药液一;
(2)将白芷、升药、丹参、杜鹃花、何首乌、白豆蔻、白术、甘草、蒲公英和黄芪混合后煎煮三次,合并滤液后浓缩,得到药液二;
(3)将芦荟低温磨碎,去肉收集汁液,得到芦荟汁;
(4)将药液一、药液二、芦荟汁和pH调节剂于搅拌装置中混匀,再加入鸦胆子油、果酸和熊果苷,搅拌均匀后得到中间产物,向中间产物中加入增稠剂和乳化稳定剂,混合均匀后,即得到所述祛疣祛斑组合物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010968593.6A CN112007060A (zh) | 2020-09-15 | 2020-09-15 | 一种祛疣祛斑组合物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010968593.6A CN112007060A (zh) | 2020-09-15 | 2020-09-15 | 一种祛疣祛斑组合物及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112007060A true CN112007060A (zh) | 2020-12-01 |
Family
ID=73522338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010968593.6A Pending CN112007060A (zh) | 2020-09-15 | 2020-09-15 | 一种祛疣祛斑组合物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112007060A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103070918A (zh) * | 2012-11-14 | 2013-05-01 | 翟立冬 | 一种可以清除hpv病毒的润体油及其制备方法 |
CN104623293A (zh) * | 2015-02-02 | 2015-05-20 | 方辉 | 一种祛斑祛疣的中药水 |
CN105496822A (zh) * | 2015-12-29 | 2016-04-20 | 苏州工业园区安诺科斯化妆品研发有限公司 | 果酸护肤液及其制备方法 |
CN111419753A (zh) * | 2020-04-28 | 2020-07-17 | 刘科勇 | 不含防腐剂的美白祛斑抗衰老安瓶精华液及其制备方法 |
-
2020
- 2020-09-15 CN CN202010968593.6A patent/CN112007060A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103070918A (zh) * | 2012-11-14 | 2013-05-01 | 翟立冬 | 一种可以清除hpv病毒的润体油及其制备方法 |
CN104623293A (zh) * | 2015-02-02 | 2015-05-20 | 方辉 | 一种祛斑祛疣的中药水 |
CN105496822A (zh) * | 2015-12-29 | 2016-04-20 | 苏州工业园区安诺科斯化妆品研发有限公司 | 果酸护肤液及其制备方法 |
CN111419753A (zh) * | 2020-04-28 | 2020-07-17 | 刘科勇 | 不含防腐剂的美白祛斑抗衰老安瓶精华液及其制备方法 |
Non-Patent Citations (3)
Title |
---|
林喵等: "《错误百出的护肤小常识》", 31 January 2013, 重庆大学出版社 * |
浙江省卫生厅编: "《浙江省中药炮制规范》", 31 July 1986, 浙江科学技术出版社 * |
贺菊乔等: "《中西医结合外科学》", 31 August 2001, 中国中医药出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104161864A (zh) | 一种健脾益胃的外用膏药及其制备方法 | |
CN106421392A (zh) | 一种治疗褥疮的中药凝胶剂及其制备方法 | |
CN105770669A (zh) | 一种用于治疗色斑的药物制剂及其用途 | |
CN102846872B (zh) | 用于治疗面瘫的中药及制备方法 | |
CN104825578A (zh) | 一种促进面神经损伤外科吻合术后康复的药物 | |
CN104435783A (zh) | 能量养生灸及其使用方法 | |
CN112007060A (zh) | 一种祛疣祛斑组合物及制备方法 | |
CN103735959B (zh) | 一种治疗瘢痕的中药组合物及其制备方法 | |
CN107617081B (zh) | 一种治疗脱发的中药组合物及其制剂与制备方法 | |
CN105853866A (zh) | 一种制备治疗褥疮的中药组合物的方法 | |
CN105327244A (zh) | 一种含有艾叶的治疗褥疮的中药组合物及其制备方法 | |
CN111202821A (zh) | 具有舒敏抗炎功效的中药提取物及其制备方法与应用 | |
CN104623040A (zh) | 一种用于创口杀菌消炎的护理组合物及其制备方法 | |
CN1141105C (zh) | 化癌药液 | |
CN104096018A (zh) | 一种治疗面部神经麻痹症的中药组合物 | |
CN108403603A (zh) | 一种樱桃山柰美容祛斑天然中药面膜膏及其制备方法 | |
CN114848789B (zh) | 一种止痛麦粒灸的介质及其制备方法 | |
CN108938858A (zh) | 一种活血化瘀膏药 | |
CN114246926B (zh) | 一种治疗皮肤疣的外用中药组合物及其制备方法和应用 | |
CN114469845B (zh) | 一种利用大胡蜂蜂针液的外用制剂及其制备方法 | |
CN113952403B (zh) | 一种用于治疗***术后放疗下肢水肿的中药膏 | |
CN115645508B (zh) | 一种用于宫颈疾病的外用中药组合物和外用制剂及其制备方法 | |
CN115192689B (zh) | 一种治疗颈肩腰腿痛的中药组合物、应用及其中药制剂 | |
CN112121119B (zh) | 一种治疗氢氟酸烧伤的药膏 | |
CN103071020B (zh) | 用于小儿气管-支气管炎、肺炎治疗的外敷软膏及其制法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201201 |
|
RJ01 | Rejection of invention patent application after publication |